Allergy/Asthma News

BOSTON — Children with atopic disease had increased risks for developing eosinophilic esophagitis, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

James M. Tracy, DO, clinical professor of pediatrics at University of Nebraska College of Medicine, is set to become the president of the American College of Allergy, Asthma & Immunology ahead of its conference, Oct. 24-28, in Boston.

Nonqualified plans offer a valuable alternative or supplement to qualified retirement plans for physicians seeking to enhance their retirement savings.

BOSTON — Physicians can take a deep dive into the current state of asthma care as the American College of Allergy, Asthma & Immunology opens its 2024 conference on Thursday, Oct. 24, with a full day dedicated to diagnosis and treatment.

October is National Eczema Awareness Month. It serves to bring attention to the approximately 16.5 million adults and 8 million children in the U.S. that currently suffer from the chronic skin condition.

BOSTON — Symptoms improved with mepolizumab after treatment with omalizumab failed for a patient with asthma who developed allergic bronchopulmonary aspergillosis, according to a poster presented at the CHEST Annual Meeting.

Necessary changes within the health care system will only arise when workers are allowed more time and space personally and professionally, with ChatGPT the method by which this transformation can occur, according to Robert Pearl, MD.

BOSTON — Lower levels of urinary club cell 16 were associated with childhood asthma, with potentially stronger associations between these lower levels and atopic childhood asthma, according to a presentation at the CHEST Annual Meeting.

BOSTON — Patients aged 65 years and older on dupilumab for asthma and chronic rhinosinusitis experienced greater risks for adverse events than younger patients, according to a poster presented at the CHEST Annual Meeting.

BOSTON — Patients with eosinophilic reactive airway disease after immune checkpoint inhibitor therapy saw improved symptoms with typical treatment for reactive airway disease, according to a study presented at the CHEST Annual Meeting.